Cambridge Investment Research Advisors
INTT icon

Cambridge Investment Research Advisors’s inTEST INTT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio INTT Stock Details INTT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-59,895
Closed -$1.57M – 3207
2023
Q2 		$1.57M Buy
+59,895
New +$1.32M 0.01% 1316

Other funds holding INTT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Cambridge Investment Research Advisors's INTT Position: Q3 2023 in Review

Cambridge Investment Research Advisors sold out of inTEST (INTT) in Q3 2023, closing a stake of 59,895 shares — an estimated $1.57M sold.

Cambridge Investment Research Advisors first reported a position in INTT in Q2 2023 and held it in 1 quarter. The position peaked at $1.57M in Q2 2023. 87 funds tracked by Wall St. Rank hold INTT as of Q3 2023.

  • Cambridge Investment Research Advisors reported no remaining inTEST position as of Q3 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 59,895 inTEST shares in Q3 2023, an estimated $1.57M.
  • Cambridge Investment Research Advisors first reported a position in inTEST in Q2 2023 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's inTEST position peaked at $1.57M in Q2 2023.
  • 87 funds tracked by Wall St. Rank held inTEST as of Q3 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.